{"organizations": [], "uuid": "277f96f8a4bf000e6fe1cdf5e75b72049da0c6d7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180503.html", "section_title": "Archive News &amp; Video for Thursday, 03 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-immunovaccine-has-applied-to-list/brief-immunovaccine-has-applied-to-list-its-common-shares-on-nasdaq-idUSFWN1SA0S5", "country": "US", "domain_rank": 408, "title": "Immunovaccine Has Applied To List Its Common Shares On Nasdaq", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-03T19:12:00.000+03:00", "replies_count": 0, "uuid": "277f96f8a4bf000e6fe1cdf5e75b72049da0c6d7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-immunovaccine-has-applied-to-list/brief-immunovaccine-has-applied-to-list-its-common-shares-on-nasdaq-idUSFWN1SA0S5", "ord_in_thread": 0, "title": "Immunovaccine Has Applied To List Its Common Shares On Nasdaq", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "immunovaccine inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 3 (Reuters) - Immunovaccine Inc:\n* IMMUNOVACCINE INC. HAS APPLIED TO LIST ITS COMMON SHARES ON NASDAQ, ANNOUNCES REVERSE STOCK SPLIT\n* IMMUNOVACCINE INC - IMPLEMENTING A CONSOLIDATION OF ITS OUTSTANDING COMMON SHARES, AND CHANGING CORPORATION NAME TO IMV INC\n* IMMUNOVACCINE - SHARE CONSOLIDATION WILL BE DONE ON BASIS OF 1 NEW SHARE FOR EVERY 3.2 CURRENTLY OUTSTANDING SHARES\n* IMMUNOVACCINE - CURRENTLY ANTICIPATES COMMON SHARES WOULD BEGIN TRADING ON NASDAQ BEFORE END OF Q2 2018 Source text for Eikon:\nOur ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-03T19:12:00.000+03:00", "crawled": "2018-05-04T16:52:56.002+03:00", "highlightTitle": ""}